Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-05

Clinical Trial Update: A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of a fixed-dose combination of amlodipine and enalapril has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Enalapril (enalapril)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED